Societe de Promotion Pharmaceutique du Maghreb Balance Sheet Health
Financial Health criteria checks 5/6
Societe de Promotion Pharmaceutique du Maghreb has a total shareholder equity of MAD483.9M and total debt of MAD131.2M, which brings its debt-to-equity ratio to 27.1%. Its total assets and total liabilities are MAD984.5M and MAD500.7M respectively. Societe de Promotion Pharmaceutique du Maghreb's EBIT is MAD88.6M making its interest coverage ratio 19.2. It has cash and short-term investments of MAD62.7M.
Key information
27.1%
Debt to equity ratio
د.م131.18m
Debt
| Interest coverage ratio | 19.2x |
| Cash | د.م62.74m |
| Equity | د.م483.87m |
| Total liabilities | د.م500.66m |
| Total assets | د.م984.53m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PRO's short term assets (MAD663.8M) exceed its short term liabilities (MAD382.3M).
Long Term Liabilities: PRO's short term assets (MAD663.8M) exceed its long term liabilities (MAD118.4M).
Debt to Equity History and Analysis
Debt Level: PRO's net debt to equity ratio (14.1%) is considered satisfactory.
Reducing Debt: PRO's debt to equity ratio has increased from 18% to 27.1% over the past 5 years.
Debt Coverage: PRO's debt is well covered by operating cash flow (87.1%).
Interest Coverage: PRO's interest payments on its debt are well covered by EBIT (19.2x coverage).